Skip to main content
OpenTrials
Completed

NCT Number: NCT00453583

Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine

This is a non-interventional retrospective data collection study from children aged from 2 to 12 years old diagnosed with an allergy and who received a treatment consisting of an H1-antihistamine. The period of last taken medication will be observed to evaluate the global satisfaction of the parents and physician for this last treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Allergies Hypersensitivity Immune System Diseases

Age range

2 year–12 year

Sex eligibility

All sexes

Study type

Observational

Primary location

UCB Pharma

Smyrna, Georgia, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children from 2-12 included
  • History of allergy
  • Used an Antihistamine within market authorization

Exclusion criteria

  • Child not yet treated for the presented allergy

Treatment and study plan

Primary outcomes

  1. Parent satisfaction on a 11-point scale

    Time frame: duration of the study

Secondary outcomes

  1. Physician satisfaction on an 11-point scale

    Time frame: duration of the study

  2. Efficacy, tolerability and global satisfaction

    Time frame: duration of the study

Sponsors and collaborators

Lead sponsor

UCB Pharma

Industry

Registry information

Official study title

Evaluation of the Treatment Satisfaction in Children Suffering From an Allergy and Who Received an Antihistamine Treatment

Important dates

Study start
2007
Primary completion
2008
Study completion
2008
First posted
Mar 29, 2007
Registry last updated
Dec 16, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.